# The Psychopharmacology of Agitation in an Inpatient Psychiatric Setting - URL: https://alisanburak.com/en/wcp-2026-posterler/ev0548 - Language: en - Last updated: not specified - Page title: The Psychopharmacology of Agitation in an Inpatient Psychiatric Setting | WCP 2026 Summary > Most patients admitted to an emergency psychiatric ward are agitated, and the most commonly used treatment is a combination of haloperidol and a benzodiazepine. This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev0548) Bu sayfa, 26. Dünya Psikiyatri Kongresi'nde sunulan çalışmanın yapay zekâ desteğiyle hazırlanmış Türkçe özetidir. Çalışmanın sahibi sunan yazarlardır; atıf için orijinal kaynağa başvurun. EV0548 E-PosterPsikofarmakolojiGeriye dönük dosya incelemesi # The Psychopharmacology of Agitation in an Inpatient Psychiatric Setting PSYCHOPHARMACOLOGY OF AGITATION IN INPATIENT PSYCHIATRIC SETTING Sunan: Vilma Videnova Ülke: North Macedonia Kurum: Psychiatric Hospital "Skopje", Male Department of Emergency Psychiatry Most patients admitted to an emergency psychiatric ward are agitated, and the most commonly used treatment is a combination of haloperidol and a benzodiazepine. The aim of the study was to examine treatment options for acute agitation in psychiatric inpatients. All adult admissions to the male emergency psychiatric ward at Skopje Psychiatric Hospital over a six-month period were retrospectively reviewed; the relationship between agitation and diagnosis, as well as treatment selection for resolving agitation, was evaluated. Diagnoses were established according to ICD-10 criteria, and patients ranged in age from 20 to 76 years (mean age: 41.4 years). Of 107 admissions, agitation was identified in 93 (87%), while 14 patients (13%) were not agitated. The diagnostic distribution among agitated patients was as follows: schizophrenia spectrum disorder in 64 patients (68.8%), personality disorder with co-occurring substance abuse in 21 patients (22.6%), intellectual disability in 5 patients (5.4%), and bipolar disorder in 3 patients (3.2%). Medications prescribed for agitation included typical antipsychotics (primarily haloperidol), benzodiazepines, and atypical antipsychotics (clozapine and olanzapine); the distribution was haloperidol plus a benzodiazepine in 48 patients (51.6%), clozapine in 16 patients (17.2%), olanzapine plus a benzodiazepine in 10 patients (10.7%), a benzodiazepine in 10 patients (10.7%), olanzapine in 5 patients (5.5%), and clozapine plus a benzodiazepine in 4 patients (4.3%). The authors emphasize that treatment selection for an agitated patient depends on the patient's clinical presentation, medication availability, and the clinician's experience; the choice of psychotropic medication should be individualized, with tolerability as the primary consideration, followed by efficacy. [Orijinal postere git](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/47) Bu çalışmaya nasıl atıf yapılır? APA 7: Videnova, V., Manusheva, N., & Mitic, Z. (2026, September 23-26). Psychopharmacology of agitation in inpatient psychiatric setting [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/47 Vancouver: Videnova V, Manusheva N, Mitic Z. Psychopharmacology of agitation in inpatient psychiatric setting [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/47 Yazar adları ve başlık biçimi kongre sisteminden otomatik oluşturulmuştur; kullanmadan önce orijinal posterle karşılaştırın. ## Aynı konudan - [Açığı kapatmak: erişkin DEHB ilacı başlanmadan önce EKG sevk uyumunun iyileştirilmesi, kapalı döngü klinik denetim](https://alisanburak.com/en/wcp-2026-posterler/ev0088) - [Anksiyete bozukluğu olan hastalarda psikobiyotik müdahalesi: ısıl işlem görmüş Lactobacillus paracasei PS23'ün etkilerini inceleyen çift kör randomize kontrollü çalışma](https://alisanburak.com/en/wcp-2026-posterler/ev0126) - [Otizm spektrum bozukluğunda bumetanidin tedavi edici potansiyeli: güncel kanıtlar ve gelecek yönelimleri](https://alisanburak.com/en/wcp-2026-posterler/ev0157) - [Verbaskozid ile otizm spektrum bozukluğu tedavisinin mekanizmaları: ağ farmakolojisi, moleküler yerleştirme ve moleküler dinamik temelli inceleme](https://alisanburak.com/en/wcp-2026-posterler/ev0172) - [Otizm spektrum bozukluğunun çekirdek belirtilerinin tedavisinde kannabidiol: sistematik derleme](https://alisanburak.com/en/wcp-2026-posterler/ev0186) [Tüm WCP 2026 özetleri](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev0548 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim